Past Highlights
Welcome to the Past Highlights page, our collection of featured publications, research, and news.

Population-level impact of initiating pharmacotherapy and linking to care persons with opioid use disorder at inpatient medically managed withdrawal programs: an effectiveness and cost effectiveness analysis
Savinkina A, Madushani RWMA, Yazdi GE, Wang J, Barocas JA, Morgan JR, Assoumou SA, Walley AY, Linas BP, Murphy SM
Recent Addiction Journal Publications
On March 21, 2022, Addiction Journal published two publications, one led by Dr. Joëlla Adams and the other led by Alexandra Savinkina, both alumni of the Syndemics Team. The publication by Adams found that offering buprenorphine treatment on-site within syringe services programs could substantially decrease drug overdoses, improve treatment engagement, and save on costs. Savinkina’s publication found that linking detox patients to outpatient care and initiating MOUD while in detox could prevent fatal overdoses among people with OUD and would be cost-effective from a healthcare sector perspective.


2022 Penn LDI/CHERISH Virtual Conference
On January 14th, Mathieu Castry and Ben Linas presented preliminary results on the projected impact of implementing state licensure standards to improve access to medications for opioid use disorder (MOUD) in residential treatment at the Penn LDI/CHERISH Virtual Conference. The conference explored how states can use licensing authorities to address gaps in access to MOUDs in treatment facilities through modeling. Learn more about Mathieu and Ben’s research and about the conference below.